Wei‐Hua Chiu

460 total citations
14 papers, 318 citations indexed

About

Wei‐Hua Chiu is a scholar working on Neurology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Wei‐Hua Chiu has authored 14 papers receiving a total of 318 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Neurology, 10 papers in Cellular and Molecular Neuroscience and 3 papers in Cognitive Neuroscience. Recurrent topics in Wei‐Hua Chiu's work include Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Nerve injury and regeneration (5 papers). Wei‐Hua Chiu is often cited by papers focused on Neurological disorders and treatments (9 papers), Parkinson's Disease Mechanisms and Treatments (9 papers) and Nerve injury and regeneration (5 papers). Wei‐Hua Chiu collaborates with scholars based in Germany, Israel and United States. Wei‐Hua Chiu's co-authors include Wolfgang H. Oertel, Günter U. Höglinger, Joshua A. Goldberg, Candan Depboylu, Vincent Ries, José de Jesús Aceves Buendía, Lukas Maurer, James B. Koprich, Jonathan M. Brotchie and Fanni F. Geibl and has published in prestigious journals such as Journal of Neuroscience, Scientific Reports and Neuroscience.

In The Last Decade

Wei‐Hua Chiu

14 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wei‐Hua Chiu Germany 11 186 171 83 40 39 14 318
Louise D. Loopuijt Netherlands 11 246 1.3× 123 0.7× 109 1.3× 27 0.7× 48 1.2× 21 374
L Bassi Italy 9 264 1.4× 171 1.0× 51 0.6× 14 0.3× 33 0.8× 11 359
Antonio Martínez-Simón Spain 8 194 1.0× 53 0.3× 97 1.2× 21 0.5× 86 2.2× 27 334
A. Meldrum United Kingdom 8 241 1.3× 91 0.5× 132 1.6× 23 0.6× 83 2.1× 10 411
Ilaria Morella Italy 12 168 0.9× 75 0.4× 189 2.3× 16 0.4× 72 1.8× 19 385
Patrick A. Howson Canada 10 224 1.2× 74 0.4× 139 1.7× 13 0.3× 47 1.2× 14 323
Sharon Bledsoe United States 6 322 1.7× 106 0.6× 126 1.5× 23 0.6× 32 0.8× 7 403
Haydn N. Allbutt Australia 10 237 1.3× 232 1.4× 87 1.0× 14 0.3× 28 0.7× 12 438
M. Bonastre Spain 14 300 1.6× 280 1.6× 97 1.2× 11 0.3× 15 0.4× 28 439
Samuel Burke Canada 5 186 1.0× 269 1.6× 112 1.3× 13 0.3× 35 0.9× 6 403

Countries citing papers authored by Wei‐Hua Chiu

Since Specialization
Citations

This map shows the geographic impact of Wei‐Hua Chiu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Hua Chiu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Hua Chiu more than expected).

Fields of papers citing papers by Wei‐Hua Chiu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Hua Chiu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Hua Chiu. The network helps show where Wei‐Hua Chiu may publish in the future.

Co-authorship network of co-authors of Wei‐Hua Chiu

This figure shows the co-authorship network connecting the top 25 collaborators of Wei‐Hua Chiu. A scholar is included among the top collaborators of Wei‐Hua Chiu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wei‐Hua Chiu. Wei‐Hua Chiu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Chiu, Wei‐Hua, et al.. (2024). Ion channel dysregulation and cellular adaptations to alpha-synuclein in stressful pacemakers of the parkinsonian brainstem. Pharmacology & Therapeutics. 260. 108683–108683. 2 indexed citations
2.
Matschke, Lina A., Martin T. Henrich, Susanne Rinné, et al.. (2022). Enhanced firing of locus coeruleus neurons and SK channel dysfunction are conserved in distinct models of prodromal Parkinson’s disease. Scientific Reports. 12(1). 3180–3180. 13 indexed citations
3.
Sakreida, Katrin, Wei‐Hua Chiu, Juergen Dukart, et al.. (2022). Disentangling dyskinesia from parkinsonism in motor structures of patients with schizophrenia. Brain Communications. 4(4). fcac190–fcac190. 12 indexed citations
4.
Chiu, Wei‐Hua, Ruth E. Musgrove, Hadar Arien‐Zakay, et al.. (2021). α-Synuclein–induced Kv4 channelopathy in mouse vagal motoneurons drives nonmotor parkinsonian symptoms. Science Advances. 7(11). 11 indexed citations
5.
Thakur, Poonam, Wei‐Hua Chiu, Jochen Roeper, & Joshua A. Goldberg. (2019). α-Synuclein 2.0 — Moving towards Cell Type Specific Pathophysiology. Neuroscience. 412. 248–256. 10 indexed citations
6.
Chiu, Wei‐Hua, et al.. (2019). Activity Patterns in the Neuropil of Striatal Cholinergic Interneurons in Freely Moving Mice Represent Their Collective Spiking Dynamics. eNeuro. 6(1). ENEURO.0351–18.2018. 20 indexed citations
7.
Henrich, Martin T., Fanni F. Geibl, Wei‐Hua Chiu, et al.. (2018). A53T-α-synuclein overexpression in murine locus coeruleus induces Parkinson’s disease-like pathology in neurons and glia. Acta Neuropathologica Communications. 6(1). 39–39. 50 indexed citations
8.
Höllerhage, Matthias, Claudia Moebius, Johannes C. Melms, et al.. (2017). Protective efficacy of phosphodiesterase-1 inhibition against alpha-synuclein toxicity revealed by compound screening in LUHMES cells. Scientific Reports. 7(1). 11469–11469. 49 indexed citations
9.
Buendía, José de Jesús Aceves, et al.. (2017). Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion. European Journal of Neuroscience. 49(6). 824–833. 24 indexed citations
10.
Klietz, Martin, Ursula Keber, Thomas Carlsson, et al.. (2016). l-DOPA-induced dyskinesia is associated with a deficient numerical downregulation of striatal tyrosine hydroxylase mRNA-expressing neurons. Neuroscience. 331. 120–133. 7 indexed citations
11.
Simchovitz, Alon, Wei‐Hua Chiu, Wolfgang H. Oertel, et al.. (2016). Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease. Journal of Neuroscience. 37(1). 47–57. 23 indexed citations
12.
Chiu, Wei‐Hua, Candan Depboylu, Lukas Maurer, et al.. (2015). Long-term treatment with l-DOPA or pramipexole affects adult neurogenesis and corresponding non-motor behavior in a mouse model of Parkinson's disease. Neuropharmacology. 95. 367–376. 50 indexed citations
13.
Chiu, Wei‐Hua, Thomas Carlsson, Candan Depboylu, et al.. (2013). Selegiline normalizes, while l-DOPA sustains the increased number of dopamine neurons in the olfactory bulb in a 6-OHDA mouse model of Parkinson's disease. Neuropharmacology. 79. 212–221. 21 indexed citations
14.
Arias-Carrión, Óscar, Elizabeth Sumi Yamada, Nils Freundlieb, et al.. (2009). Neurogenesis in Substantia Nigra of Parkinsonian Brains?. PubMed. 279–285. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026